See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

Experimental mRNA vaccines gain steam with promising cancer trial results

Posted on AllSides June 4th, 2024
From The Left
REUTERS/Dado Ruvic/Illustration

Pharmaceutical giants Moderna and Merck announced promising results from a clinical trial testing a combined treatment of an mRNA vaccine and immunotherapy for skin cancer. Melanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower chances of cancer recurrence and spread, as well as higher survival rates, than those who received Keytruda alone.

Read full story

AllSides Picks

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right